SPOTLIGHT -
rTMS for Clozapine-Refractory Schizophrenia
TMS for TRS? Researchers analyzed data to identify all randomized-controlled trials of rTMS versus sham treatment in patients with hard-to-treat forms of schizophrenia. Here’s what they found.
Read More
Neuroprotective Effects of Antidepressants in First-Episode Schizophrenia
Negative symptoms, subsyndromal depressive symptoms, and functional impairment often persist in patients with first-episode schizophrenia.
Relevant Patient Odors for Mental Status Examinations
Utilizing our senses-sight, hearing, AND smell-during the patient interview can provide a comprehensive exam and assist in assessment and treatment.
Increased Protein Insolubility in Brains of Some Patients with Schizophrenia
Protein insolubility has been found to occur in a subset of patients with schizophrenia.
The FDA on ECT: Supporting a Vital Treatment
This new FDA order now allows patients who need and want ECT, as well as practitioners who perform it, to breathe a sigh of relief.
Mini Quiz: Schizophrenia Research
Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia. Take the quiz and learn more.
Mitigation of Olanzapine-Induced Weight Gain: Not the Sami Old Thing
Promising results from a phase 2 trial of olanzapine plus samidorphan in patients with schizophrenia.
Smartphone Social Behavior and Relapse in Schizophrenia
Changes in social behavior on a mobile device may indicate relapse risk that could be assessed in the clinical setting.
Looking Ahead: Tardive Dyskinesia Care
Recent studies and reviews report great progress in bringing TD under control.
What’s New in Schizophrenia and Cardiovascular Disease?
5 questions to test your skills, based on recent findings in the literature.
Neurobiology and Clinical Management of Childhood Onset Schizophrenia
Although psychotic illnesses are fortunately rare in children, contrary to common belief, psychotic symptoms can be fairly common in very young healthy children.
Cannabidiol as an Adjunctive Treatment for Schizophrenia
Cannabis continues to be the most commonly used illicit drug in the US, and the potential beneficial effects of CBD on cognition in patients with schizophrenia have critical importance.
Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia
Schizophrenia in Later Life: Patient Characteristics and Treatment Strategies
With the prevalence of schizophrenia in older adults set to double and reach 1.1 million people in the US by 2025, greater attention to research and policy regarding this population is needed.
Cognitive Training for Neural System Dysfunction in Psychotic Disorders
Tardive Dyskinesia Quiz: Medical Comorbidities
In this quiz, learn which medical disorders patients with schizophrenia and comorbid TD are likely to contend with.
Vitamin Supplementation for First-Episode Psychosis?
New research considers the effects of folic acid, vitamin B6, and vitamin B12 supplementation on symptom and neurocognitive outcomes in patients with FEP.
Tardive Dyskinesia Quiz: Scales, Syndromes, and Spontaneity
Tardive syndromes include a broad spectrum of abnormal movements. Which movement disorders can resemble tardive dyskinesia? Find out in the quiz.
Introduction: Convergence of Thought?
Peter F. Buckley, MD introduces part 1 of our Special Report on schizophrenia.
Immunotherapy as Personalized Medicine for Schizophrenia?
Two compelling case reports provide additional evidence for potential mechanistic associations between the immune system and schizophrenia.
Understanding the Risks and Benefits of Antipsychotic Polypharmacy
Antipsychotic drugs are the cornerstone in the management of psychotic disorders, but most patients fail to have a “good” response in short-term trials. Alternative strategies are presented here.
Project Untangled: A Journey of Hope and Healing
Many trauma survivors do not enjoy their life due to their daily struggles with memories in the aftermath. Wounded healers are no exception. More in this Portrait of a Psychiatrist.
The Infection-Psychosis Connection
Are psychiatric disorders such as schizophrenia and depression triggered by infections in early life?
Mini Quiz: Supported Housing for Vulnerable Patients
What factors are associated with loss of supported housing for chronically homeless patients with serious mental illnesss? Take the quiz and learn more.
The Dog That Did Not Bark
Some thoughts on the pathogenesis and persistence of prevalence of schizophrenia and bipolar affective disorder in view of current discoveries.
High Intensity Interval Training in Patients With Psychosis
Physical activity should be considered an important part of the management of metabolic complications in patients with psychotic disorders.
5 New Questions on Sleep Disorders and Psychosis
Sleep disruption is often overlooked in treatment planning for patients with psychotic disorders. Recent research provides insights in this 5-question quiz.
Neutrophil Count Is Associated With Reduced Gray Matter and Enlarged Ventricles in First-Episode Psychosis
Given the evidence for progressive gray matter volume loss in first-episode psychosis, it is possible that leukocyte infiltration may contribute to brain tissue loss.
Mini Quiz: Antipsychotics in Women
In some cases, treatment with antipsychotics can pose risks in women. Take the quiz and learn more.
Reducing Suicide Risk: The Role of Psychotherapy
This article provides a brief synopsis of the research regarding the use of psychotherapy to manage suicidal behavior, followed by several examples of strategies that such treatment employs.